Renal dysfunction in cirrhosis is not just a vasomotor nephropathy.
Adebayo D, Morabito V, Davenport A, Jalan R.
Kidney Int. 2015 Mar;87(3):509-15. doi: 10.1038/ki.2014.338. Epub 2014 Oct 8.
Vasomotor nephropathy.
Berman LB.
JAMA. 1975 Mar 10;231(10):1067-9.
Vasomotor nephropathy in the elderly.
Andreucci VE, Fuiano G, Russo D, Andreucci M.
Nephrol Dial Transplant. 1998;13 Suppl 7:17-24. doi: 10.1093/ndt/13.suppl_7.17.
Cryoglobulinemic vasculitis: pathophysiological mechanisms and diagnosis.
Kolopp-Sarda MN, Miossec P.
Curr Opin Rheumatol. 2021 Jan;33(1):1-7. doi: 10.1097/BOR.0000000000000757.
Renal autoregulation in health and disease.
Carlström M, Wilcox CS, Arendshorst WJ.
Physiol Rev. 2015 Apr;95(2):405-511. doi: 10.1152/physrev.00042.2012.
Renal blood flow regulation, autoregulation, and vasomotor nephropathy.
Sladen RN, Landry D.
Anesthesiol Clin North Am. 2000 Dec;18(4):791-807, ix. doi: 10.1016/s0889-8537(05)70195-4.
Intravascular hemolysis and the pathophysiology of sickle cell disease.
Kato GJ, Steinberg MH, Gladwin MT.
J Clin Invest. 2017 Mar 1;127(3):750-760. doi: 10.1172/JCI89741. Epub 2017 Mar 1.
Fezolinetant.
[No authors listed]
2024 Oct 10. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Acute renal failure (vasomotor nephropathy): micropuncture studies of the pathogenetic mechanisms.
Oken DE.
Annu Rev Med. 1975;26:307-19. doi: 10.1146/annurev.me.26.020175.001515.
Hepatorenal syndrome and type 1 and 2 cardiorenal syndromes: distinct competing medical therapies applied to a similar background of vasomotor reactive nephropathy.
De Vecchis R, Esposito C, Di Biase G, Ariano C.
Minerva Cardioangiol. 2014 Feb;62(1):105-16.
